Skip to main content

Home/ INVESTING IN THE STOCK MARKET/ Group items tagged Norway

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Equities Group

Does Bayer Look like a Buy? | equities.com - 0 views

editorial.equities.com/...ug-makes-bayer-look-like-a-buy

investing stocks equities.com Bayer Brittney Barrett oncology drug economy European debt contagion investors risk wall street biotech danger volatility Denderon BAYRY Germany Norway Algeta prostate cancer Alpharadin tumors radiation data symptoms bones pa

shared by Equities Group on 28 Sep 11 - No Cached
  • Equities Group on 28 Sep 11
     
    The late stage studies of Bayer's oncology drug, Alpharadin are impressive to say the least. Designed for the treatment of prostate cancer that spreads to the bones, the drug is able to extend life of late-stage patients while minimizing damage to healthy tissue.
1 - 1 of 1
Showing 20▼ items per page